BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11897155)

  • 1. Molecular characterization of a ligand-tethered parathyroid hormone receptor.
    Monticelli L; Mammi S; Mierke DF
    Biophys Chem; 2002 Feb; 95(2):165-72. PubMed ID: 11897155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor.
    Greenberg Z; Bisello A; Mierke DF; Rosenblatt M; Chorev M
    Biochemistry; 2000 Jul; 39(28):8142-52. PubMed ID: 10889020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
    Turner PR; Mefford S; Bambino T; Nissenson RA
    J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
    Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues.
    Tsomaia N; Pellegrini M; Hyde K; Gardella TJ; Mierke DF
    Biochemistry; 2004 Jan; 43(3):690-9. PubMed ID: 14730973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residue 19 of the parathyroid hormone: structural consequences.
    Piserchio A; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2002 Nov; 41(44):13217-23. PubMed ID: 12403623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR; Usdin TB
    Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the receptor-ligand complex for parathyroid hormone.
    Rölz C; Pellegrini M; Mierke DF
    Biochemistry; 1999 May; 38(20):6397-405. PubMed ID: 10350457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop.
    Piserchio A; Bisello A; Rosenblatt M; Chorev M; Mierke DF
    Biochemistry; 2000 Jul; 39(28):8153-60. PubMed ID: 10889021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking.
    Behar V; Bisello A; Rosenblatt M; Chorev M
    Endocrinology; 1999 Sep; 140(9):4251-61. PubMed ID: 10465299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor.
    Dean T; Khatri A; Potetinova Z; Willick GE; Gardella TJ
    J Biol Chem; 2006 Oct; 281(43):32485-95. PubMed ID: 16923805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding domain of human parathyroid hormone receptor: from conformation to function.
    Pellegrini M; Bisello A; Rosenblatt M; Chorev M; Mierke DF
    Biochemistry; 1998 Sep; 37(37):12737-43. PubMed ID: 9737850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor.
    Shimizu M; Shimizu N; Tsang JC; Petroni BD; Khatri A; Potts JT; Gardella TJ
    Biochemistry; 2002 Nov; 41(44):13224-33. PubMed ID: 12403624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple regions of ligand discrimination revealed by analysis of chimeric parathyroid hormone 2 (PTH2) and PTH/PTH-related peptide (PTHrP) receptors.
    Clark JA; Bonner TI; Kim AS; Usdin TB
    Mol Endocrinol; 1998 Feb; 12(2):193-206. PubMed ID: 9482662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone.
    Adams AE; Bisello A; Chorev M; Rosenblatt M; Suva LJ
    Mol Endocrinol; 1998 Nov; 12(11):1673-83. PubMed ID: 9817594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation.
    Pioszak AA; Harikumar KG; Parker NR; Miller LJ; Xu HE
    J Biol Chem; 2010 Apr; 285(16):12435-44. PubMed ID: 20172855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor.
    Gensure RC; Shimizu N; Tsang J; Gardella TJ
    Mol Endocrinol; 2003 Dec; 17(12):2647-58. PubMed ID: 12947048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.
    Assil IQ; Qi LJ; Arai M; Shomali M; Abou-Samra AB
    Biochemistry; 2001 Feb; 40(5):1187-95. PubMed ID: 11170443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies.
    Mannstadt M; Luck MD; Gardella TJ; Jüppner H
    J Biol Chem; 1998 Jul; 273(27):16890-6. PubMed ID: 9642250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.